RSN Fehrmann

About RSN Fehrmann

RSN Fehrmann, With an exceptional h-index of 47 and a recent h-index of 42 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of Oncology, Bioinformatics, Artificial Intelligence, Investigator-drive trials, biobanking.

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring combinations of dimensionality reduction, transfer learning, and regularization methods for predicting binary phenotypes with transcriptomic data

Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases

Identification of new head and neck squamous cell carcinoma molecular imaging targets

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

MET-receptor targeted fluorescent imaging and spectroscopy for primary papillary thyroid cancer detection

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics

Infrastructure for rare cancer in the Netherlands: Towards a comprehensive platform for early detection and diagnosis of rare cancers (FORCE).

RSN Fehrmann Information

University

Position

University Medical Center Groningen

Citations(all)

21109

Citations(since 2020)

10714

Cited By

15077

hIndex(all)

47

hIndex(since 2020)

42

i10Index(all)

85

i10Index(since 2020)

77

Email

University Profile Page

Google Scholar

RSN Fehrmann Skills & Research Interests

Oncology

Bioinformatics

Artificial Intelligence

Investigator-drive trials

biobanking

Top articles of RSN Fehrmann

Exploring combinations of dimensionality reduction, transfer learning, and regularization methods for predicting binary phenotypes with transcriptomic data

BMC Bioinformatics

2024/12

Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases

American Journal of Otolaryngology

2024/4/16

Identification of new head and neck squamous cell carcinoma molecular imaging targets

Oral Oncology

2024/4/1

MET-receptor targeted fluorescent imaging and spectroscopy for primary papillary thyroid cancer detection

European Journal of Surgical Oncology

2024/2/1

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

ESMO open

2023/8/1

Rsn Fehrmann
Rsn Fehrmann

H-Index: 33

FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics

Cell reports

2023/7/25

Infrastructure for rare cancer in the Netherlands: Towards a comprehensive platform for early detection and diagnosis of rare cancers (FORCE).

2023/6/1

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

Cancers

2023/5/26

Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

2023/5/8

Association of a Mediterranean diet with outcomes for patients treated with immune checkpoint blockade for advanced melanoma

JAMA oncology

2023/5/1

Opportunities on the horizon for the management of early colon cancer

2023/3/1

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

Bmc cancer

2023/2/18

Andere ontwikkelingen in het kankeronderzoek: Toepassing kunstmatige intelligentie in de oncologie

2023/2/2

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

ESMO open

2023/2/1

Rsn Fehrmann
Rsn Fehrmann

H-Index: 33

2286P COVID-19 vaccinations in cancer patients (pts): An individual participant data meta-analysis of the International Consortium on COVID vaccination in cancer

Annals of Oncology

2023/10/1

Rsn Fehrmann
Rsn Fehrmann

H-Index: 33

Current state and prospects of artificial intelligence in allergy

2023/10

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

The Lancet Oncology

2022/7/1

Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation

Cell death & disease

2022/6/28

Eliminating copy number alteration effects in the gene essentiality data from the Cancer Dependency Map project

Cancer Research

2022/6/15

See List of Professors in RSN Fehrmann University(Rijksuniversiteit Groningen)

Co-Authors

academic-engine